Future-Proofing the Diagnostic Ecosystem: Meet at WHX Labs 2026

BioPerfectus announces the WHX Labs Dubai 2026 launch of its SAW-48 Automated Nucleic Acid Extraction system (Customization) and Lyofastra lyophilized PCR reagent series—solutions designed to strengthen laboratory operations against supply-chain disruptions, cold-chain dependencies, and workflow inefficiencies.

Key Features Delivering Resilience:
Lyofastra PCR Kits:

  • Ambient-stable (2–30℃ storage, -20–45℃ transport) with an 18-month shelf life.
  • Reduce waste by 50% and lower cold-chain logistics costs.
  • Validated for multiple pathogens, such as Monkeypox, Ebola and etc., showing 100% sensitivity/specificity after 12 months.

SAW-48 Automation System:

  • Open-architecture design compatible with third-party reagents.
  • Processes 48 samples in 45 minutes, supporting diverse sample types (blood, swabs, urine).
  • Compact footprint ideal for small-to-mid size labs, enabling up to 245 tests/day.

Future Glimpse:
SHT-A2: Fully Automated Nucleic Acid Extraction and Real-time PCR Analysis System

SAW-DM32: Automated Nucleic Acid Extraction and Purification Workstation for Methylation Detection

Visit BioPerfectus at WHX Labs Dubai 2026

See how Lyofastra and SAW-48 create a seamless, sustainable diagnostic pipeline. Explore live demos, on-site workshop, and partnership opportunities at Booth [H3,B50]. 

Learn More